EdiGene is a clinical-stage company focused on translating gene-editing technologies into transformative genetic medicines for patients with significant unmet medical needs. Anchored by its proprietary technologies of gene editing, bioinformatics, and high throughput genome-editing screening, EdiGene advances the pipeline on therapeutic platforms of LEAPER-based in vivo RNA base editing, ex vivo gene-editing hematopoietic stem cells, and ex vivo gene-editing T cells for allogeneic CAR-T.
View Top Employees from EdiGene Inc.| Website | http://www.edigene.com/ |
| Revenue | $23 million |
| Funding | $154.5 million |
| Employees | 46 (29 on RocketReach) |
| Founded | 2015 |
| Address | Building 2 22 Science Park Road Zhongguancun Life Science Park, Changping District, Beijing, CN |
| Phone | +86 10 8073 3899 |
| Technologies |
HTML,
G Suite,
Gmail
+1 more
(view full list)
|
| Industry | Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Enterprise |
| Competitors | Applied StemCell, Editas Medicine, Intellia Therapeutics, Inc., Precision BioSciences, Inc., Visterra Inc. |
| SIC | SIC Code 28 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 6215 Companies, NAICS Code 325413 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 62 Companies, NAICS Code 621 Companies, NAICS Code 62151 Companies, NAICS Code 3254 Companies |
Looking for a particular EdiGene Inc. employee's phone or email?
EdiGene Inc. Questions
The EdiGene Inc. annual revenue was $23 million in 2024.
Ruby Ru is the Head of Human Resources of EdiGene Inc..
29 people are employed at EdiGene Inc..
EdiGene Inc. is based in Changping District, Beijing.
The NAICS codes for EdiGene Inc. are [32541, 6215, 325413, 32, 325, 62, 621, 62151, 3254].
The SIC codes for EdiGene Inc. are [28, 87].
Top EdiGene Inc. Employees
-
3
-
22
-
1
-
1
-
2
-
1
-
2
Related Companies
